Evidence map›Paper›PMID 33032614›Full record

ArticleMalaria journal2020

Researchers' perceptions of malaria eradication: findings from a mixed-methods analysis of a large online survey.

Joe Brew, Menno Pradhan, Jacqueline Broerse, Quique Bassat

Abstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Pathology of Severe Malaria.Pathogens (Basel, Switzerland) · 2023
    Article
  2. Diagnostic Methods for Non-Falciparum Malaria.Frontiers in cellular and infection microbiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joe BrewBarcelona Institute for Global Health, Hospital Clinic, c/Rosselló, 132, 5è 2a, 08036, Barcelona, Spain. joebrew@gmail.com.ORCID http://orcid.org/0000-0002-4119-0117
Menno PradhanVrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV, Amsterdam, Netherlands.
Jacqueline BroerseVrije Universiteit Amsterdam, De Boelelaan 1105, 1081 HV, Amsterdam, Netherlands.
Quique BassatBarcelona Institute for Global Health, Hospital Clinic, c/Rosselló, 132, 5è 2a, 08036, Barcelona, Spain.

Funding

European Commission Erasmus Mundus Fellowship
6 · The paper itself

Abstract

backgroundThe value of malaria eradication, the permanent reduction to zero of the worldwide incidence of malaria infection caused by human malaria parasites, would be enormous. However, the expected value of an investment in an intended, but uncertain, outcome hinges on the probability of, and time until, its fulfilment. Though the long-term benefits of global malaria eradication promise to be large, the upfront costs and uncertainty regarding feasibility and timeframe make it difficult for policymakers and researchers to forecast the return on investment.

methodsA large online survey of 844 peer-reviewed malaria researchers of different scientific backgrounds administered in order to estimate the probability and time frame of eradication. Adjustments were made for potential selection bias, and thematic analysis of free text comments was carried out.

resultsThe average perceived likelihood of global eradication among malaria researchers approximates the number of years into the future: approximately 10% of researchers believe that eradication will occur in the next 10 years, 30% believe it will occur in the next 30 years, and half believe eradication will require 50 years or more. Researchers who gave free form comments highlighted systemic challenges and the need for innovation as chief among obstacles to achieving global malaria eradication.

conclusionsThe findings highlight the difficulty and complexity of malaria eradication, and can be used in prospective cost-benefit analyses to inform stakeholders regarding the likely return on eradication-specific investments.

Indexed as

Disease EradicationHumansMalariaResearch PersonnelCrowdsourcingEliminationEradicationMalariaMixed methodsOpportunity costProbabilitySurvey

Identifiers

PMID33032614
PMCPMC7545840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.